GREY:IMVIF - Post by User
Post by
Hideawayon Apr 15, 2019 9:09am
80 Views
Post# 29626758
Next News Cycle
Next News CycleAside from the Bloom Burton presentation on May 1st, there are no scheduled announcements until June as pe the following:
| | |
| | |
| | |
| | |
| | |
| | |
Phase 2 monotherapy results in Ovarian - ASCO | |
Phase 1/1b monotherapy long term follow-up - ASCO | |
Phase 2 clinical results with Merck Keytruda in DLBCL - ICML | |
June is a pivitol month for IVM, but in the absence of new announcements, our shareprice may indeed go lower as the technicals indicate. I hope not below $4 but who knows what the markets hold. May can signal the beginning of the summer doldrums when juniors can begin to shed some of their previous gains.
If I was not already over-invested in IVM,it could create a great buying opportunity,but this is still a very speculative situation and I an hesitant to add.
Anyway June looks interesting and should give us much more clrification on our future with IVM.
Anyone else see potential drivers for May?
GLTA | |
| | |
| | |
| | |